Canada · Delayed Price · Currency is CAD AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of CAD 646.50 billion. The enterprise value is 736.20 billion.
| Market Cap | 646.50B |
| Enterprise Value | 736.20B |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Oct 15, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 76.66% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 72.61 and the forward PE ratio is 17.33.
| PE Ratio | 72.61 |
| Forward PE | 17.33 |
| PS Ratio | 7.07 |
| PB Ratio | -77.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.00 |
| P/OCF Ratio | 23.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.96, with an EV/FCF ratio of 28.47.
| EV / Earnings | 82.68 |
| EV / Sales | 8.20 |
| EV / EBITDA | 16.96 |
| EV / EBIT | 23.07 |
| EV / FCF | 28.47 |
Financial Position
The company has a current ratio of 0.81
| Current Ratio | 0.81 |
| Quick Ratio | 0.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.28 |
| Debt / FCF | 3.89 |
| Interest Coverage | 7.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 10.51% |
| Return on Invested Capital (ROIC) | 17.70% |
| Return on Capital Employed (ROCE) | 24.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.60M |
| Profits Per Employee | 156,211 |
| Employee Count | 57,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, AbbVie has paid 3.38 billion in taxes.
| Income Tax | 3.38B |
| Effective Tax Rate | 27.39% |
Stock Price Statistics
The stock price has increased by +18.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +18.84% |
| 50-Day Moving Average | 35.54 |
| 200-Day Moving Average | 32.13 |
| Relative Strength Index (RSI) | 59.90 |
| Average Volume (20 Days) | 2,647 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.08 |
Income Statement
In the last 12 months, AbbVie had revenue of CAD 91.43 billion and earned 8.90 billion in profits. Earnings per share was 5.03.
| Revenue | 91.43B |
| Gross Profit | 66.56B |
| Operating Income | 32.51B |
| Pretax Income | 12.35B |
| Net Income | 8.90B |
| EBITDA | 43.69B |
| EBIT | 32.51B |
| Earnings Per Share (EPS) | 5.03 |
Balance Sheet
The company has 9.33 billion in cash and 100.66 billion in debt, with a net cash position of -91.34 billion.
| Cash & Cash Equivalents | 9.33B |
| Total Debt | 100.66B |
| Net Cash | -91.34B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -8.36B |
| Book Value Per Share | -4.77 |
| Working Capital | -11.32B |
Cash Flow
In the last 12 months, operating cash flow was 27.70 billion and capital expenditures -1.84 billion, giving a free cash flow of 25.86 billion.
| Operating Cash Flow | 27.70B |
| Capital Expenditures | -1.84B |
| Depreciation & Amortization | 11.00B |
| Net Borrowing | 584.41M |
| Free Cash Flow | 25.86B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.79%, with operating and profit margins of 35.56% and 9.80%.
| Gross Margin | 72.79% |
| Operating Margin | 35.56% |
| Pretax Margin | 13.51% |
| Profit Margin | 9.80% |
| EBITDA Margin | 47.78% |
| EBIT Margin | 35.56% |
| FCF Margin | 28.73% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 3.26%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 3.26% |
| Dividend Growth (YoY) | 28.19% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 189.83% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 3.27% |
| Earnings Yield | 1.38% |
| FCF Yield | 4.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AbbVie has an Altman Z-Score of 2.42 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.42 |
| Piotroski F-Score | 8 |